---
title: "Distinct Proteomic Programs and Disease Risks Linked to Age-Related Clonal Hematopoiesis and Mosai"
id: "medrxiv-3-age-related-clonal-hematopoiesis-and-mosaic-sex-chromosome-loss-define-distinct"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-age-related-clonal-hematopoiesis-and-mosaic-sex-chromosome-loss-define-distinct"
content_type: "clinical_feed_article"
specialty: "Hematology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Distinct Proteomic Programs and Disease Risks Linked to Age-Related Clonal Hematopoiesis and Mosai
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-age-related-clonal-hematopoiesis-and-mosaic-sex-chromosome-loss-define-distinct
- **Specialty:** [Hematology](https://medichelpline.com/clinical-feed/hematology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This UK Biobank analysis evaluated age-related hematopoietic clones and sex chromosome mosaicism in 450,587 participants, with plasma proteomics available for 46,324 individuals. - The study compared **clonal hematopoiesis** of indeterminate potential (CHIP) and mosaic loss of chromosome Y (**mLOY**) or X (**mLOX**) across ageing, incident disease, and circulating proteins. - Although CHIP, mLOY and mLOX all increase with age, they were associated with different disease spectra rather than representing a single ageing signature. - **Non-DNMT3A CHIP** (CHIP excluding DNMT3A-mutant clones) associated with a broad multisystem disease burden. - **mLOY** showed a more focused pattern of disease associations, notably respiratory, musculoskeletal and cardiovascular conditions. - **mLOX** did not show broad age-related disease links in these analyses. - Clone burden (extent of mosaicism or CHIP clone size) mapped to distinct circulating proteomic programs: mLOY linked to pathways of neutrophil degranulation and extracellular matrix remodeling; non-DNMT3A CHIP to myeloid immune regulation; and mLOX unexpectedly to cytotoxic lymphocyte and NK-cell response signatures. - Mendelian randomization analyses supported selected protein–disease relationships identified in the proteomic mapping. - The authors conclude that age-related hematopoietic clones are not interchangeable markers of ageing but define alteration-specific systemic programs and disease vulnerabilities. - Ethical and data access notes: analyses used UK Biobank data under application 170256; UK Biobank approval and participant consent were documented.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=IbpiBoEqtX5iYNJIEMWjh2c1lEyhm3UhqoySpYKpERg-1788231038.100834-1.2.1.1-AX9aZcCEQd_IXobRDryZNEOiw3Tyx7bTviJD4p3L1o9szL1lklGXWV6AM55ouV8p) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilities Michael Weyrich, Akshay Ware, Agnes Steixner-Kumar, Johannes Windschmitt, Tamim Sarakpi, Wesley Abplanalp, Stefanie Dimmeler, Thimoteus Speer, Andreas M Zeiher doi: https://doi.org/10.64898/2026.08.29.26361722 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Michael Weyrich 1 Goethe-University Frankfurt, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BWeyrich%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Weyrich%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BWeyrich%2B) Akshay Ware 2 Institute of Cardiovascular Regeneration; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Akshay%2BWare%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ware%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAkshay%2BWare%2B) Agnes Steixner-Kumar 1 Goethe-University Frankfurt, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Agnes%2BSteixner-Kumar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Steixner-Kumar%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAgnes%2BSteixner-Kumar%2B) Johannes Windschmitt 1 Goethe-University Frankfurt, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Johannes%2BWindschmitt%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Windschmitt%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJohannes%2BWindschmitt%2B) Tamim Sarakpi 1 Goethe-University Frankfurt, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tamim%2BSarakpi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sarakpi%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATamim%2BSarakpi%2B) Wesley Abplanalp 1 Goethe-University Frankfurt, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Wesley%2BAbplanalp%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Abplanalp%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AWesley%2BAbplanalp%2B) Stefanie Dimmeler 3 Goethe University Frankfurt; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stefanie%2BDimmeler%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dimmeler%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStefanie%2BDimmeler%2B) Thimoteus Speer 4 Goethe-University Frankfurt * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Thimoteus%2BSpeer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Speer%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AThimoteus%2BSpeer%2B) Andreas M Zeiher 1 Goethe-University Frankfurt, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andreas%2BM%2BZeiher%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zeiher%20AM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndreas%2BM%2BZeiher%2B) * For correspondence: zeiher@em.uni-frankfurt.de * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289339/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289339/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289339/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289339/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289339/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Clonal hematopoiesis (CH) increases with age, but whether different somatic clones represent an ageing phenotype or exert distinct systemic effects is unclear. In 450,587 UK Biobank participants, including 46,324 with plasma proteomics, we compared clonal hematopoiesis of indeterminate potential (CHIP) and mosaic loss of chromosome Y (mLOY) or X (mLOX) across biological ageing, incident disease, and circulating proteins. Despite shared age dependence, these alterations showed distinct disease spectra: non-DNMT3A CHIP was associated with broad multisystem disease burden, mLOY with a more focused respiratory, musculoskeletal and cardiovascular profile, whereas mLOX lacked broad age-related disease associations. Clone burden mapped to distinct proteomic programs: mLOY to neutrophil degranulation and extracellular-matrix remodeling, non-DNMT3A CHIP to myeloid immune regulation, and mLOX unexpectedly to cytotoxic lymphocyte/NK-cell responses. Mendelian randomization supported selected protein-disease relationships. Thus, age-related hematopoietic clones are not interchangeable markers of ageing but define alteration-specific systemic programs associated with distinct disease vulnerabilities. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: UK Biobank operates with approval from the North West Multi-center Research Ethics Committee (11/NW/0382), and all participants provided informed consent. The present analyses were conducted under UK Biobank application 170256. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability UK Biobank data are available to bona fide researchers through the UK Biobank access procedure. These analyses were conducted under application 170256. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.26.26361468v1 "The dynamics of arterial pressure itself predict intraoperative hypotension beyond its current value: an interpretable additive model validated in 3,069 external patients under a selection-bias-resistant protocol")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.29.26361707v1 "Adverse drug withdrawal event signals in FAERS and Eudravigilance databases: a stratified disproportionality analysis study") Posted August 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/31/2026.08.29.26361722.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.29.26361722v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/31/2026.08.29.26361722.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilities Michael Weyrich, Akshay Ware, Agnes Steixner-Kumar, Johannes Windschmitt, Tamim Sarakpi, Wesley Abplanalp, Stefanie Dimmeler, Thimoteus Speer, Andreas M Zeiher medRxiv 2026.08.29.26361722; doi: https://doi.org/10.64898/2026.08.29.26361722 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.29.26361722v1%26text%3DAge-related%2520clonal%2520hematopoiesis%2520and%2520mosaic%2520sex%2520chromosome%2520loss%2520define%2520distinct%2520systemic%2520proteomic%2520programs%2520and%2520disease%2520vulnerabilities "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.29.26361722v1%26t%3DAge-related%2520clonal%2520hematopoiesis%2520and%2520mosaic%2520sex%2520chromosome%2520loss%2520define%2520distinct%2520systemic%2520proteomic%2520programs%2520and%2520disease%2520vulnerabilities "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.29.26361722v1%26title%3DAge-related%2520clonal%2520hematopoiesis%2520and%2520mosaic%2520sex%2520chromosome%2520loss%2520define%2520distinct%2520systemic%2520proteomic%2520programs%2520and%2520disease%2520vulnerabilities%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.29.26361722v1%26title%3DAge-related%2520clonal%2520hematopoiesis%2520and%2520mosaic%2520sex%2520chromosome%2520loss%2520define%2520distinct%2520systemic%2520proteomic%2520programs%2520and%2520disease%2520vulnerabilities "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.29.26361722) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.29.26361722v1&count=horizontal&via=&text=Age-related%20clonal%20hematopoiesis%20and%20mosaic%20sex%20chromosome%20loss%20define%20distinct%20systemic%20proteomic%20programs%20and%20disease%20vulnerabilities&counturl=www.medrxiv.org/content/10.64898/2026.08.29.26361722v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (613) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (895) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (326) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4766) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (643) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1613) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15828) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6980) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1057) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4974) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1425) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1734) * [Hematology](https://www.medrxiv.org/collection/hematology) (579) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1333) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16241) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1160) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (720) * [Neurology](https://www.medrxiv.org/collection/neurology) (7188) * [Nursing](https://www.medrxiv.org/collection/nursing) (363) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1072) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1230) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1000) * [Oncology](https://www.medrxiv.org/collection/oncology) (3568) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1036) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (446) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (465) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1772) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (732) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5828) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9686) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2386) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1432) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1239) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (633) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (765) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (575) * [Surgery](https://www.medrxiv.org/collection/surgery) (766) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (302) * [Urology](https://www.medrxiv.org/collection/urology) (286) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs
## Related Clinical Research

- [Mean Platelet Volume and Disease Severity in Paediatric Sickle Cell Anaemia in Kwara State, Nigeria](https://medichelpline.com/clinical-feed/medrxiv-18-evaluating-mean-platelet-volume-in-relation-to-disease-severity-in-paediatric.md)
- [North West London Diabetes Cohort: multiethnic EHR resource for diabetes complications research](https://medichelpline.com/clinical-feed/bmj-open-2-large-scale-multiethnic-electronic-health-record-resource-for-diabetes.md)
- [VR Headset Pupillometry Detects RAPD and Pathological Anisocoria: Study Results](https://medichelpline.com/clinical-feed/medrxiv-1-pupil-symmetry-and-swinging-light-test-performed-with-vr-headset-for-detection.md)
- [Readers’ reactions: M.D. vs D.O., AI and physician autonomy, surrogacy, postpartum psychiatry, and](https://medichelpline.com/clinical-feed/stat-news-0-opinion-what-stat-readers-think-about-m-d-vs-d-o-ai-in-medicine-surrogacy-and.md)
- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)

## Navigation
- [← Back to Hematology Feed](https://medichelpline.com/clinical-feed/hematology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.